For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
0
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      The impact of indacaterol/glycopyrronium fixed-dose combination versus tiotropium monotherapy on lung function and treatment preference: a randomized crossover study - the FAVOR study.

      Author(s):
      Publication date:
      Journal: International Journal of Chronic Obstructive Pulmonary Disease
      Publisher: Dove Medical Press Ltd.
      Keywords: indacaterol/glycopyrronium, dual bronchodilators, FEV1, COPD, treatment preference, treatment choice

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The objective of the FAVOR study was to evaluate the effect of indacaterol/glycopyrronium (IND/GLY) versus tiotropium on peak forced expiratory volume in 1 s (FEV1) and also to investigate patient satisfaction and treatment preference.

          Related collections

          Author and article information

          Journal
          PubMed ID:: 29317812
          PMC ID:: 5744738
          DOI:: 10.2147/COPD.S146189

          Keywords: indacaterol/glycopyrronium,dual bronchodilators,FEV1,COPD,treatment preference,treatment choice
          Data availability:
          Keywords: indacaterol/glycopyrronium, dual bronchodilators, FEV1, COPD, treatment preference, treatment choice

          Comments

          Comment on this article

          scite_